Hyperparathyroidism is common in XLH patients and thought to be the result of stimulation of parathyroid cells by FGF23 and by oral phosphate supplementation but could also be related to vitamin D deficiency [6, 47, 48]. This evidence concerns the gene FGF23 and hyperparathyroidism.